Abstract

SummaryBackgroundThe effect of the COVID-19 pandemic on HIV outcomes in low-income and middle-income countries is poorly described. We aimed to measure the impact of the 2020 national COVID-19 lockdown on HIV testing and treatment in KwaZulu-Natal, South Africa, where 1·7 million people are living with HIV.MethodsIn this interrupted time series analysis, we analysed anonymised programmatic data from 65 primary care clinics in KwaZulu-Natal province, South Africa. We included data from people testing for HIV, initiating antiretroviral therapy (ART), and collecting ART at participating clinics during the study period, with no age restrictions. We used descriptive statistics to summarise demographic and clinical data, and present crude summaries of the main outcomes of numbers of HIV tests per month, ART initiations per week, and ART collection visits per week, before and after the national lockdown that began on March 27, 2020. We used Poisson segmented regression models to estimate the immediate impact of the lockdown on these outcomes, as well as post-lockdown trends.FindingsBetween Jan 1, 2018, and July 31, 2020, we recorded 1 315 439 HIV tests. Between Jan 1, 2018, and June 15, 2020, we recorded 71 142 ART initiations and 2 319 992 ART collection visits. We recorded a median of 41 926 HIV tests per month before lockdown (January, 2018, to March, 2020; IQR 37 838–51 069) and a median of 38 911 HIV tests per month after lockdown (April, 2020, to July, 2020; IQR 32 699–42 756). In the Poisson regression model, taking into account long-term trends, lockdown was associated with an estimated 47·6% decrease in HIV testing in April, 2020 (incidence rate ratio [IRR] 0·524, 95% CI 0·446–0·615). ART initiations decreased from a median of 571 per week before lockdown (IQR 498–678), to 375 per week after lockdown (331–399), with an estimated 46·2% decrease in the Poisson regression model in the first week of lockdown (March 30, 2020, to April 5, 2020; IRR 0·538, 0·459–0·630). There was no marked change in the number of ART collection visits (median 18 519 visits per week before lockdown [IQR 17 074–19 922] vs 17 863 visits per week after lockdown [17 509–18 995]; estimated effect in the first week of lockdown IRR 0·932, 95% CI 0·794–1·093). As restrictions eased, HIV testing and ART initiations gradually improved towards pre-lockdown levels (slope change 1·183/month, 95% CI 1·113–1·256 for HIV testing; 1·156/month, 1·085–1·230 for ART initiations).InterpretationART provision was generally maintained during the 2020 COVID-19 lockdown, but HIV testing and ART initiations were heavily impacted. Strategies to increase testing and treatment initiation should be implemented.FundingWellcome Trust, Africa Oxford Initiative.

Highlights

  • The number of deaths from COVID-19 continues to rise globally, but data quantifying the effect of the pandemic on other health conditions are scarce, especially in low-income and middle-income countries

  • We aimed to quantify the impact of COVID-19 lockdown in South Africa on key components of HIV care, namely HIV testing, antiretroviral therapy (ART) initiation, and retention in HIV care, which was measured using ART collection visits and missed visits

  • ART is provided free of charge at all these clinics, and they remained open during the South African national lockdown

Read more

Summary

Introduction

The number of deaths from COVID-19 continues to rise globally, but data quantifying the effect of the pandemic on other health conditions are scarce, especially in low-income and middle-income countries. Interruption of supply chains, diversion of resources, and overwhelmed health systems could have severe collateral effects on existing public health programmes.[1,2,3,4] COVID-19 control measures, such as stay-at-home orders, or lockdowns, might limit access to health-care services, further jeopardising broader public health goals.[3,5,6]. Modelling studies of dis­ ruptions to HIV programmes by the COVID-19 pandemic estimate that interruptions in ART would have the largest effect on HIV-related mortality.[8,9] In a worst case scenario, interruption of ART for 6 months for 50% of patients would result in 296 000 excess HIV-related deaths.[8]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.